All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network

The MPN Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

The world-leading experts in MPN shared the top abstracts from ASH 2020 that they believe could have the greatest impact on clinical practice.

In this document, you will find comments from the MPN Hub Steering Committee members on the impact of mutation for MPN development and progression as well as exciting results from studies using novel drugs for the treatment of myelofibrosis and polycythemia vera. Furthermore, the latest data exploring the optimized use of interferon alpha will be featured.

ASH 2020 | Practice-changing abstracts in myeloproliferative neoplasms

Did you miss ASH 2020? Download the resource below to view the practice-changing abstracts and the expert opinions from our Steering Committee.

Download Here


Share:
More about...